Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.
about
Hepatitis E PathogenesisMolecular Biology and Infection of Hepatitis E VirusTherapeutic targets for the treatment of hepatitis E virus infectionAdvances in hepatitis E - I: virology, pathogenesis and diagnosis.Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif.Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant.Hepatitis E virus ORF2 protein over-expressed by baculovirus in hepatoma cells, efficiently encapsidates and transmits the viral RNA to naïve cells.New Methods in Tissue Engineering: Improved Models for Viral InfectionThermal stability of hepatitis E virus assessed by a molecular biological approachAdaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.Authentication of the R06E fruit bat cell line.Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.Rescue of a genotype 4 human hepatitis E virus from cloned cDNA and characterization of intergenotypic chimeric viruses in cultured human liver cells and in pigs.Cutthroat Trout Virus-Towards a Virus Model to Support Hepatitis E Research.Hepatitis E virus infection.Hepatitis E virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levelsAutochthonous hepatitis e virus infections: a new transfusion-associated risk?Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood.Culture systems for hepatitis E virus.Features of hepatitis E virus infection in humans and animals in Japan.Hepatitis E: latest developments in knowledge.Hepatitis E genotype 4 virus from feces of monkeys infected experimentally can be cultured in PLC/PRF/5 cells and upregulate host interferon-inducible genes.Potential Approaches to Assess the Infectivity of Hepatitis E Virus in Pork Products: A Review.Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis.A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food.Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.HEV Cell Culture.Hepatitis E virus: advances and challenges.Engineered Livers for Infectious Diseases.Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.Hepatitis E Virus Induces Hepatocyte Apoptosis via Mitochondrial Pathway in Mongolian Gerbils.
P2860
Q26741395-956E6CD3-DCDE-489C-9AE2-6FDE6AB6846FQ28066101-78D7D0DD-6BF8-4CE6-86C7-E269A300CD07Q28084036-5AD4E9D1-0F41-4966-B015-BC6346DDC5B8Q30250366-6E50CE4E-2CE5-42B3-B2EB-636B3C7EEB8CQ33769640-AECD188A-3BF0-4FAD-86BB-C9347474DDE6Q34120153-404AAB41-B30B-4D21-A5E8-5E80B1667D19Q34572927-9EB28749-956E-4A19-BD95-DC06FCBD7DA6Q34871606-1FAAB5DE-A377-44AE-BFF5-5D4848EA62CDQ35431256-24625D13-3B6B-40E7-87F9-D6315ED77AF7Q35549672-090397CD-2A79-45DC-9DB9-C2C33D274C8AQ35943622-876A4772-2B55-4773-B256-94A36B62AB55Q35960539-A9713037-5A55-45FB-A7DD-406D9C4E3987Q36067726-DD5A4B18-CD15-48D8-AF89-700B01D8CE14Q36171812-8980CC68-DFAE-4F4B-98EA-E97B77F53272Q36523201-66D19301-646B-40C7-A7F8-67258BB467FBQ37378838-6B2DEE75-49F4-404E-BA68-E00A72E80BD5Q37544935-A810E781-FAF6-44F2-8F8F-32A17DF7741FQ37547561-6EC3D43F-AD07-470B-BDC4-CDBD23B83709Q37630325-27A094D2-6ED7-4284-842E-36F669A76E16Q37835780-FACF0330-6E34-4F04-8259-DA9104EC145BQ38056078-7715F999-2F79-4E2D-808B-1DB1F733A8B0Q38110609-D89D8615-1EB1-472F-9786-82852FD23D9FQ38839954-0DBB130B-B476-4328-8695-2F07406A6532Q38973769-9AF89A10-5514-41F4-A151-6AB51C80CF00Q39282511-B562AB84-AA43-4791-AF0E-1A5C584FA520Q39351405-543D680F-EFCA-4391-BCA7-C80056FB9ABAQ39448901-FD2EB5B0-928F-4DBB-BDB5-0AA899B8DF98Q40055037-A37ABD5B-BF36-4679-B9DA-53DF2CC83E0EQ40507429-AE57A8F4-2CD6-4FE2-A8DA-9A5044C19B74Q45324469-43B2E74B-068F-4DFA-BE69-32F48CD87EBCQ47555660-6A990985-4E7A-4713-AD92-87988D653E80Q49953709-43A3D171-4358-4867-B376-17E086D7A59DQ54242435-4D2471D6-C56A-4CB7-8853-CAB5223B0A54
P2860
Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and characterizati ...... a fulminant hepatitis patient.
@en
Development and characterizati ...... a fulminant hepatitis patient.
@nl
type
label
Development and characterizati ...... a fulminant hepatitis patient.
@en
Development and characterizati ...... a fulminant hepatitis patient.
@nl
prefLabel
Development and characterizati ...... a fulminant hepatitis patient.
@en
Development and characterizati ...... a fulminant hepatitis patient.
@nl
P2093
P2860
P356
P1476
Development and characterizati ...... a fulminant hepatitis patient
@en
P2093
Hideyuki Takahashi
Hitoshi Mizuo
Koji Ichiyama
Masaharu Takahashi
Shigeo Nagashima
Toshinori Tanaka
Yu Hoshino
P2860
P304
P356
10.1128/JCM.00629-09
P407
P577
2009-04-15T00:00:00Z